RT Journal Article SR Electronic T1 Understanding the spreading patterns of COVID-19 in UK and its impact on exit strategies JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.05.18.20105445 DO 10.1101/2020.05.18.20105445 A1 Nekovee, Maziar YR 2020 UL http://medrxiv.org/content/early/2020/05/21/2020.05.18.20105445.abstract AB Prior to lockdown the spread of COVID-19 in UK is found to be exponential, with an exponent α=0.207. In case of COVID-19 this spreading behaviour is quantitatively better described with a mobility-driven SIR-SEIR model [2] rather than the homogenous mixing models Lockdown has dramatically slowed down the spread of COVID-19 in UK, and even more significantly, has changed the growth in the total number of infected from exponential to quadratic. This significant change is due to a transition from a mobility-driven epidemic spreading to a spatial epidemic which is dominated by slow growth of spatially isolated clusters of infected population. Our results strongly indicate that, to avoid a return to exponential growth of COVID-19 (also known as “second wave”), mobility restrictions should not be prematurely lifted. Instead mobility should be kept restricted while new measures, such as wearing of masks and contact tracing, get implemented in order to prevent health services becoming overwhelmed due to a resurgence of exponential growth.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was partially funded by UK Economic and Social Research Council (ESRC) through an Impact Acceleator Account.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is publicly available. https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public